identification of novel fusions and pharmacogenomic targets in cancer
Published 7 years ago • 1.5K plays • Length 54:13Download video MP4
Download video MP3
Similar videos
-
33:05
comparing fusion detection assays using sarcoma samples
-
55:52
comprehensive ntrk fusion detection, agnostic of the fusion ..
-
2:31
the role of gene fusions for cancer screening and targeted therapies
-
46:26
characterizing targeted cancer therapies via a comprehensive gene fusion database
-
42:29
tumor evolution in the transcriptome, epigenome, and epitranscriptome
-
4:30
jeffrey rosenfeld│long read sequencing of tumor rna and dna to analyze fusions and amplicons
-
4:46
what are the standard methods to detect ntrk fusions in daily practice and clinical research?
-
5:45
pharmacogenomics ~direct-to-consumer genetic testing~ (23andme)
-
57:03
pharmacogenomics: the gene’s role in cancer treatment | focus on cancer s1e5
-
7:20
pharmacogenomics: genes and medicine
-
2:28
part 1 - pharmacogenomics in research & clinical practice
-
1:01:57
michael f berger - genomic approaches to discover biomarkers of drug response in cancer
-
1:08:04
lecture 12: pharmacogenomics
-
2:35
removing cancer’s veil: trusight tumor 170 gene panel
-
31:41
e03.2 pharmacogenomic testing in clinical practice
-
43:49
genetic testing and pharmacogenetics
-
40:09
pharmacogenomics study of anti-cancer
-
22:34
pharmacogenomic prediction of antracycline-induced cardiotoxicity
-
38:20
cancer genomics and pharmacogenomics